Medium 5.5Published Jun 23, 2026

CVE-2026-56693NanoClaw < 2.1.17 - Privilege Escalation via Unauthorized create_agent System Action

Updated under an hour ago (Oct 28, 2026, 12:50 AM ET)

Does this affect you?

It affects nanocoai nanoclaw. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Do this next

Start free and add your stack

Free account, 1 product

Every CVE for nanocoai nanoclaw

Exploited in the last 30 days

NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the create_agent delivery-action handler that performs privileged central-database writes without host-side authorization checks. Confined agent containers can invoke create_agent to create arbitrary agent groups, container configurations, and destinations, escalating beyond their intended confinement boundary.

CVSS: 5.5 MEDIUM (v3.1, CNA)CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N
Weakness (CWE): CWE-602
Known exploited: Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days): Not loaded for this CVE
Assigned by: VulnCheck
NVD analysis: Deferred
Record last updated: Sep 17, 2026
First seen by InfoSec Signals: Oct 9, 2026

Affected products

Affected products

nanocoai nanoclaw nanocoai:nanoclaw (from the name)	before 2.1.17; 2.1.17 not affected	CNA record

References

References

https://github.com/nanocoai/nanoclaw/pull/2720	issue-tracking, patch
https://github.com/nanocoai/nanoclaw/commit/ac37ecbfd6b9d14fdfa1598a6412a8ffdbeaef45	patch
https://www.vulncheck.com/advisories/nanoclaw-privilege-escalation-via-unauthorized-create-agent-system-action	third-party-advisory

The CVE record on cve.org NVD's entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.